---
title: Cyagen Biosciences vs Inotiv
slug_a: cyagen
slug_b: inotivco
site: cro
review_signal_gate: closed
canonical_path: /compare/cyagen/inotivco
generated_by: BioBM Editorial AI
---

# Cyagen Biosciences vs Inotiv

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Cyagen Biosciences (cyagen) is listed for cro. Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.

Services: 8. Modalities: 4. Indications: 7. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Inotiv (inotivco) is listed for cro. Inotiv provides integrated preclinical and safety assessment services including toxicology, bioanalysis, pathology, and specialized research models across discovery through IND-enabling phases.

Services: 21. Modalities: 2. Indications: 9. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (21).

Review summary: Review summary withheld until site-level review gate opens.